Date
Attendees
| Committee Member | Present | Absent |
|---|---|---|
| X | ||
| X | ||
| X | ||
| X | ||
| Gregory Tawa | X | |
| William Hendriks | X | |
| Matthew Breen | X | |
| Roel Verhaak | X |
Goals
- Review, discuss, and prioritize ICDC study submission proposals
Outstanding Action items
- Determine if Matthew Breen will speak at next Steering Committee meeting about possibilities for cross-referencing data about WGS, WES, airborne contaminants, pathology, etc. and a central repo for canine data as it relates to all comparative mechanisms (let's push this out to not the next, but the Steering Committee meeting on x date). Targeting June presentation.
Discussion items
| Item | Who | Notes |
|---|---|---|
| Testing Access to Files in SharePoint | ||
| New Data Submission Request: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases | ||
| Test case for Osteosarcoma data from candidate publication list will be recommended to the SAC when clinical metadata is received | ||
| Data Use Guidelines (DUG) and Intellectual Policy Statement | Kuffel, Gina (NIH/NCI) [C] | |
| Study Updates |
|
Minutes (Not Verbatim)
WK - How do we get other ICs involved in participating in ICDC expansion? Maybe a working group for data integration for ICDC? Greg is a rep for NCATS.
MB - Potentially formalize the plan in the minutes of Steering Committee, formalize an action item for Toby and others.
WK - Expand lifespan of companion animals, perhaps there can be a coalition.
MB - Business plan for ICDC including aims, costs, etc. Invite the involvement of other ICs
WK - Is the nanostring data/devices able to produce whole transcriptome data? (Nanostring recently released software update that enables whole transcriptome data).
Action items
- Matthew & Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
- Musk, Philip (NIH/NCI) [C] to brush up on Nanostring documentation.
